Terumo (OTCMKTS:TRUMY) Shares Gap Down - Here's What Happened

Key Points

• Terumo Corp. shares opened at $15.64, down from a previous close of $16.30, indicating a gap down in trading before the market opened on Monday.
• The company reported a quarterly earnings of $0.20 EPS, surpassing expectations of $0.17, but fell short on revenue with $1.76 billion against a consensus estimate of $1.80 billion.
• Terumo has a market capitalization of $24.08 billion, with a current ratio of 2.64 and a debt-to-equity ratio of 0.07, highlighting strong liquidity and low debt levels.

Shares of Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $16.30, but opened at $15.64. Terumo shares last traded at $16.31, with a volume of 15,869 shares.

Terumo Price Performance

The company has a market capitalization of $24.08 billion, a P/E ratio of 28.54 and a beta of 0.79. The firm's fifty day moving average is $17.62 and its 200 day moving average is $18.12. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.53 and a current ratio of 2.64.

Terumo (OTCMKTS:TRUMY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.17 by $0.03. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.80 billion. Terumo had a net margin of 12.09% and a return on equity of 9.19%.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.